ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,251.33
1.27%
Dow Jones
40,415.44
0.32%
Brent Oil
81.535
0.02%
Bitcoin
66,496.41
-1.64%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Galera Therapeutics Inc (GRTX)

  7. Galera Therapeutics Inc (GRTX) News

GRTX

Galera Therapeutics (GRTX)

Galera Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GRTX
DateTimeSourceHeadlineSymbolCompany
06/07/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
06/03/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
05/16/202410:26AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
05/16/202410:26AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRTXGalera Therapeutics Inc
05/16/202410:25AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GRTXGalera Therapeutics Inc
05/13/20247:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTXGalera Therapeutics Inc
05/13/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
05/13/20247:00AMGlobeNewswire Inc.Galera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
05/03/20247:00AMGlobeNewswire Inc.Galera Adopts Limited Duration Stockholder Rights AgreementNASDAQ:GRTXGalera Therapeutics Inc
03/28/20247:00AMGlobeNewswire Inc.Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
02/26/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
02/20/20246:57PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GRTXGalera Therapeutics Inc
01/16/20246:11PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
11/14/20237:00AMGlobeNewswire Inc.Galera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
11/13/20232:24PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GRTXGalera Therapeutics Inc
10/31/20238:09AMDow Jones NewsGalera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 TrialNASDAQ:GRTXGalera Therapeutics Inc
10/31/20237:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
10/31/20237:00AMGlobeNewswire Inc.Galera Announces Receipt of Type A Meeting Minutes and Strategic UpdateNASDAQ:GRTXGalera Therapeutics Inc
09/26/20237:24AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
09/22/20235:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
09/18/20237:00AMGlobeNewswire Inc.Galera Schedules Type A Meeting with FDA to Discuss Next Steps for AvasopasemNASDAQ:GRTXGalera Therapeutics Inc
09/05/20237:00AMGlobeNewswire Inc.Galera to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:GRTXGalera Therapeutics Inc
08/14/20237:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTXGalera Therapeutics Inc
08/14/20237:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
08/14/20237:00AMGlobeNewswire Inc.Galera Reports Second Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
08/10/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
08/09/20238:10PMDow Jones NewsStocks to Watch: Applovin, Disney, Galera TherapeuticsNASDAQ:GRTXGalera Therapeutics Inc
08/09/20235:23PMDow Jones NewsGalera Therapeutics to Reduce Workforce by 70% to Extend Cash RunwayNASDAQ:GRTXGalera Therapeutics Inc
08/09/20234:31PMGlobeNewswire Inc.Galera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseNASDAQ:GRTXGalera Therapeutics Inc
07/05/20234:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GRTX

Your Recent History

USOTC
IDVV
International Endeavors (PK)
NYSE
AMC
AMC Entertainment
USOTC
MGON
Megola (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
GRLT
Grillit (PK)
USOTC
CNNA
Cann American (CE)
USOTC
NBRI
North Bay Resources (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
LWLG
Lightwave Logic
USOTC
FNMA
Fannie Mae (QB)
USOTC
HIRU
Hiru (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved